We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
-8.45%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$3.03B
AUM Growth
-$263M
Cap. Flow
+$136M
Cap. Flow %
4.51%
Top 10 Hldgs %
30.94%
Holding
140
New
22
Increased
32
Reduced
18
Closed
16

Top Buys

Rank Stock Value
1
SMAR
Smartsheet Inc.
SMAR
+$46.4M
2
POOL icon
Pool Corp
POOL
+$35.7M
3
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$34.3M
4
ODFL icon
Old Dominion Freight Line
ODFL
+$22M
5
LII icon
Lennox International
LII
+$14.4M

Top Sells

Rank Stock Value
1
TLND
Talend S.A. American Depositary Shares
TLND
+$26.6M
2
STLD icon
Steel Dynamics
STLD
+$22.8M
3
XPO icon
XPO
XPO
+$21.4M
4
PS
Pluralsight, Inc. Class A Common Stock
PS
+$19.6M
5
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$16.3M

Sector Composition

Rank Sector Weight
1 Healthcare 42.23%
2 Technology 22.61%
3 Industrials 11.22%
4 Consumer Discretionary 8.19%
5 Utilities 2.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STML
26
DELISTED
Stemline Therapeutics, Inc.
STML
$43.3M 1.43%
4,160,608
+967,881
+30% +$12.7M
TMX
27
DELISTED
Terminix Global Holdings, Inc.
TMX
$41.9M 1.39%
750,000
+52,000
+7% +$2.87M
POOL icon
28
Pool Corp
POOL
$6.95B
$37.3M 1.23%
+185,000
New +$35.7M
SMAR
29
DELISTED
Smartsheet Inc.
SMAR
$35.1M 1.16%
+975,000
New +$46.4M
BPMC
30
DELISTED
Blueprint Medicines
BPMC
$33.9M 1.12%
462,000
– –
IPHI
31
DELISTED
INPHI CORPORATION
IPHI
$33.9M 1.12%
555,000
– –
MYOK
32
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$32.4M 1.07%
621,000
– –
NBIX icon
33
Neurocrine Biosciences
NBIX
$18.7B
$31.8M 1.05%
353,000
– –
MGA icon
34
Magna International
MGA
$19B
$31.3M 1.03%
587,000
– –
DNTH icon
35
Dianthus Therapeutics
DNTH
$6.16B
$30.3M 1%
184,715
-33,737
-15% -$6.41M
CTAS icon
36
Cintas
CTAS
$82.7B
$29.8M 0.98%
444,000
– –
PAYC icon
37
Paycom
PAYC
$7.53B
$29.5M 0.98%
141,000
– –
PEGI
38
DELISTED
Pattern Energy Group Inc. Class A
PEGI
$28.9M 0.95%
1,073,200
– –
IDXX icon
39
Idexx Laboratories
IDXX
$44.1B
$28M 0.92%
102,900
– –
ANET icon
40
Arista Networks
ANET
$215B
$28M 0.92%
1,872,000
– –
COLL icon
41
Collegium Pharmaceutical
COLL
$1.17B
$27.9M 0.92%
2,427,976
– –
LKFT
42
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.81B
$26.4M 0.87%
173,000
– –
ARGX icon
43
argenx
ARGX
$54.6B
$26.2M 0.87%
230,000
+77,000
+50% +$10.4M
GBT
44
DELISTED
Global Blood Therapeutics, Inc.
GBT
$26M 0.86%
535,000
– –
IAA
45
DELISTED
IAA, Inc. Common Stock
IAA
$25.5M 0.84%
610,000
– –
VRNS icon
46
Varonis Systems
VRNS
$4.58B
$25.1M 0.83%
1,260,000
– –
APTV icon
47
Aptiv
APTV
$12.3B
$25M 0.83%
286,000
+800
+0.3% +$66.8K
MYOV
48
DELISTED
Myovant Sciences Ltd.
MYOV
$24.4M 0.81%
4,694,917
+409,305
+10% +$3.04M
MRTX
49
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$23.5M 0.77%
301,000
+58,000
+24% +$5.44M
ODFL icon
50
Old Dominion Freight Line
ODFL
$44.2B
$22.9M 0.76%
+405,000
New +$22M
1
2
3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2019 Portfolio in Review

As of Q3 2019, Eventide Asset Management held 140 positions worth $3.03B, down 8% from $3.29B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Eventide Asset Management deployed $136M of net new capital in Q3 2019, opening 22 new positions and adding to 32 existing holdings. Its largest new stake was Smartsheet Inc.: 975,000 shares worth $35.1M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 48% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was XPO, an estimated $21.4M trimmed.

  • Eventide Asset Management's largest Q3 2019 buy was Smartsheet Inc.: 975,000 shares worth $35.1M.
  • Eventide Asset Management added most to Biohaven Pharmaceutical Holding Company Ltd. in Q3 2019, an estimated $34.3M increase.
  • Eventide Asset Management's biggest Q3 2019 reduction was XPO, cutting an estimated $21.4M.
  • Eventide Asset Management fully exited Talend S.A. American Depositary Shares in Q3 2019, selling an estimated $26.6M.
  • Eventide Asset Management's ten largest holdings make up 31% of its $3.03B portfolio in Q3 2019.
  • Eventide Asset Management opened 22 new positions and closed 16 in Q3 2019.
  • Eventide Asset Management's portfolio value fell 8% quarter-over-quarter to $3.03B.

Based on Eventide Asset Management's 13F filing for Q3 2019, filed 21 Nov 2019.